Strong controls needed for extractables and leachables says MHRA

posted by Phill Allen

February, 18th, 2015

Company News Pharmaceutical Industry News

The Medicine and Healthcare products Regulatory Agency has underscored the need for strong controls around extractables and leachables in pharmaceutical development.
Strong controls need for extractables and leachables says MHRA
Dr Melaine Pires, senior pharmaceutical assessor at the MHRA, outlined existing regulatory  guidelines to delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
Risks surrounding extractables and leachables included interfering with drug efficacy.
As such, Dr Pires said discussions were underway to harmonise legislation in key drug development regions around the world.

TAGS: extractable, leachables, The Medicine and Healthcare products Regulatory Agency,

SHARE:

Author

Phill Allen

Managing Director

Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.

The use of bioprocessing containers in chemical bioprocessing
Pharmaceutical Industry News

The use of bioprocessing containers in chemical bioprocessing

From environmentally friendly biochemicals to cleaner energy, chemical bioprocessing is growing in importance as we look to a more sustainable […]

Oct 07th, 2025

Biopharmaceutical fluid management products
Pharmaceutical Industry News

Biopharmaceutical fluid management products

Sep 15th, 2025